/ Print /

Pharmacy Strategy

ICER-VA alliance for formulary management sparks debateThe National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.
Ten ways hospitals can manage rising drug costs
Ten ways hospitals can manage rising drug costsFluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
Guided therapy can improve antibiotic resistanceResearchers share surprising findings about PCT-guided therapy in antibiotic management in patients with respiratory infections.
Five questions for CVS Health’s Troyen A. Brennan, MD, MPHCVS Health’s Troyen A. Brennan, MD, MPH, brings attention to a unique specialty pharmacy model and value-based contracting.
CMS plan to slash 340B payments under fire by hospitalsHere are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.
Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Don’t let your tools to curb the opioid epidemic go to wasteNew public opinion survey about opioid use from Prime Therapeutics has surprising results.
Biosimilars can save billions of healthcare dollarsAnalysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.
Potential CVS-Aetna merger: Top 6 industry implicationsHealthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.
Payers struggle to keep up with high rate of FDA drug approvalsFDA incentives have hastened the development of “orphan drugs” for rare diseases, but some worry that regulators are not always demanding clear evidence for drug efficacy.